Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.
Russell H
RH
Wiesner
Michael
M
Sorrell
Federico
F
Villamil
D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006526:Hepatitis C / Q000150:complications / Q000517:prevention & control / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000601:surgery* / Q000821:virology; D016031:Liver Transplantation / Q000276:immunology; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012086:Reoperation; D012254:Ribavirin / Q000627:therapeutic use; D012307:Risk Factors
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D012254:Ribavirin